Publications by authors named "N Fuwa"

Article Synopsis
  • Streptococcal toxic shock syndrome (STSS) is a severe condition mainly caused by beta-hemolytic streptococci (BHS), with the study investigating other BHS species' roles in STSS development.
  • The study analyzed medical records from 2002 to 2022, identifying 43 STSS cases and examining their clinical features compared to 285 non-STSS cases, while factoring in age and diabetes.
  • Results showed a high mortality rate of about 35% in STSS cases, with certain BHS species being more strongly associated with STSS than others, highlighting the need for further understanding of these infections.
View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors can effectively treat recurrent and metastatic head and neck cancers, but they come with risks of immune-related adverse events (irAEs) due to systemic administration.
  • A study was conducted where tumor-bearing mice received either a standard dose or a low local dose of PD-L1 antibodies to evaluate their antitumor efficacy and immune response.
  • Results showed that the local low-dose treatment was just as effective as the systemic standard-dose treatment in reducing tumors, with increased levels of important immune proteins in the low-dose group, indicating a promising strategy for treating oral squamous cell carcinoma.
View Article and Find Full Text PDF
Article Synopsis
  • EG.5.1 is a new subvariant of the Omicron XBB variant of SARS-CoV-2 that is becoming more common globally, but its pathogenicity and immune evasion are still not well understood.
  • Research shows that EG.5.1 has similar growth ability and pathogenicity as XBB.1.5 in hamsters, but it spreads more effectively than the older BA.2 variant.
  • Additionally, plasma from recovered patients shows less neutralizing activity against EG.5.1 compared to XBB.1.5, suggesting that these differences might be contributing to its rise in prevalence among humans.
View Article and Find Full Text PDF

Superselective intra-arterial chemoradiotherapy (SSIACRT) is one of the curative treatments for advanced oral cancer. SSIACRT can reportedly treat cervical lymph node metastases in the level I-IIA area by super selectively catheterizing the facial artery (FA) and infusing drugs. However, since advanced oral cancer lesions involve a number of feeding vessels, retrograde treatment requires the placement of catheters from the superficial temporal artery (STA) and occipital artery (OA).

View Article and Find Full Text PDF

We report 4 cases of hypopharyngeal cancer preoperatively suspected with synchronous lymph node metastases. Pathologic lymph node metastasis was confirmed in three of the four cases. All 4 cases underwent endoscopic laryngopharyngeal surgery (ELPS) combined with endoscopic submucosal dissection (ESD) and subsequent lymph node dissection as an optional treatment rather than the standard treatment.

View Article and Find Full Text PDF